Bipartisan Majority Of American Voters Support Marijuana Legalization, New Poll Finds After Trump Orders Rescheduling – Marijuana Moment
Bipartisan Majority Of American Voters Support Marijuana Legalization, New Poll Finds After Trump Orders Rescheduling
Virginia’s Incoming Governor Lists Priorities She Wants In Marijuana Sales Legalization Bill If She’s Going To Sign It
Arizona Ballot Measure Seeks To Roll Back Marijuana Legalization
Major Nurses Associations Applaud Trump’s Marijuana Rescheduling Move, Saying It Could Open Doors To Critical Research
DOJ Could Ignore Trump’s Marijuana Rescheduling Directive, Congressional Researchers Suggest
Medical Marijuana Use Is ‘Prevalent’ Among People With Disabilities—And It Helps Treat Pain, New Federally Funded Study Shows
Teen Marijuana Use ‘Remained Stable’ As Legalization Expands, Federal Health Officials Acknowledge
CBD Provides Pain Relief, Improves Sleep And Aids Relaxation, Study Involving Olympic Athletes Shows
Marijuana Components ‘Effectively Inhibited Ovarian Cancer Cell Growth,’ Study Shows
Legal Marijuana Access Reduces Suicide Rates For Older Adults, New Study Suggests
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
As More Americans Choose Marijuana Over Alcohol, Mainstream Media Notices The ‘Cousin Walk’ Thanksgiving Tradition
Joe Rogan Slams ‘Really Bad’ Federal Hemp Ban Trump Signed, Blaming Alcohol Industry For Influencing Congress
New Netflix Documentary Shows How Psychedelics Help Military Veterans Heal Trauma
Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows
Marijuana Company Sues DoorDash, Total Wine And Others Over Alleged Illegal Sales Of Hemp THC Products
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Target Begins Selling THC-Infused Cannabis Drinks As Congress Debates Possible Hemp Law Reversal
No, Carrier Pigeons Will Not Be Delivering Marijuana In New York, Retailer Confirms After Marketing Stunt Fools Media Outlets
Details on feds’ CBD Medicare coverage program (Newsletter: December 29, 2025)
Federal cannabis legalization commission proposed under Senate bill (Newsletter: December 24, 2025)
Will cannabis rescheduling affect drug testing for safety-sensitive workers? (Newsletter: December 23, 2025)
Trump lied about cannabis rescheduling opposition, GOP senator says (Newsletter: December 22, 2025)
Trump signs cannabis rescheduling order (Newsletter: December 19, 2025)
Published
on
By
A bipartisan majority of American voters across nearly all major demographics—age, race, gender and political affiliation—support legalizing marijuana, according to a new poll released just days after President Donald Trump issued an executive order directing agencies to enact the more incremental reform of cannabis rescheduling.
The survey, conducted by JL Partners and commissioned by The Daily Mail, showed that 53 percent of registered U.S. voters back legalization. That includes 62 percent of Democrats and 51 percent of Republicans.
The poll asked simply: “Would you support or oppose legalizing marijuana?”
While there was majority support among all age demographics, those 30-49 years old were the more supportive at 61 percent. But even 50 percent of those 65 and older, historically the most conservative age category, back the policy change.
Fifty-eight percent of men favor legalization, while 50 percent of women support the reform.
The survey involved interviews with 1,000 registered voters from December 20-21. That means it was conducted beginning just two days after Trump directed the attorney general to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
The move wouldn’t federally legalize cannabis, however, and administration officials stressed at the signing ceremony for the rescheduling order that legalization was not their intent.
What rescheduling would do, however, is symbolically recognize the medical value of marijuana, allow cannabis businesses to take federal tax deductions and loosen certain research barriers associated with Schedule I drugs.
The latest poll from the Daily Mail is generally consistent with the growing bipartisanship around marijuana legalization, but another recent survey from YouGov showed Republicans evenly divided on the issue, with 41 percent in favor and 41 percent against the broader reform.
However, bipartisan majorities of Americans said in that survey that they support federally rescheduling marijuana.
Separately, a majority of respondents in the YouGov poll (76 percent) also said marijuana either “definitely” (43 percent) or “probably” (33 percent) has “legitimate medical uses.” On that question, there was also bipartisan agreement. Democrats were most likely to say cannabis has medical value (84 percent), followed by independents (74 percent) and Republicans (73 percent).
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
The rescheduling process initiated by the Biden administration, which Trump has now asked to be finalized, is still pending. Congressional researchers also recently released a report noting that there’s a chance the Justice Department could opt to start the process all over again, or even not complete it at all. But as prior polling has indicated, it’s a politically popular reform across the aisle.
The president said this month that cannabis can “make people feel much better” and serve as a “substitute for addictive and potentially lethal opioid painkillers.” He clarified, however, that he personally has no interest in using marijuana himself.
Trump also dismissed the concerns of GOP lawmakers who oppose rescheduling, pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people—including his personal friends—who are suffering from serious health issues.
Photo courtesy of Chris Wallis // Side Pocket Images.
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. He’s covered drug policy for more than a decade—specializing in state and federal marijuana and psychedelics issues at publications that also include High Times, VICE and attn. In 2022, Jaeger was named Benzinga’s Cannabis Policy Reporter of the Year.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2025 Marijuana Moment LLC ® and Tom Angell